Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bupiyichang pill is a Traditional Chinese Medicine (TCM) formulation used primarily for the treatment of gastrointestinal disorders, including diarrhea-predominant irritable bowel syndrome (IBS-D) and chronic colitis. It is designed to tonify the spleen and benefit the intestines according to TCM principles. The formulation typically contains a blend of herbs such as *Astragalus membranaceus*, *Codonopsis pilosula*, and *Atractylodes macrocephala*. In clinical settings, it has been evaluated for its efficacy in reducing abdominal pain and improving stool consistency, often compared to conventional treatments like pinaverium bromide. It is manufactured by companies such as Guangzhou Baiyunshan Chen Li Ji Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bupiyichang pill.